Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)	Total	Preferred Stock Series B Preferred Stock	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Dec. 31, 2023		4,676	74,166,262
Beginning balance at Dec. 31, 2023	$ 51,769,087	$ 47	$ 74,166	$ 123,125,007	$ (71,434,754)	$ 4,621
Stock based compensation	805,634			805,634
Vesting of restricted stock units (in shares)			116,247
Vesting of restricted stock units	(9,651)		$ 116	(9,767)
Net loss	(6,781,080)				(6,781,080)
Ending balance (in shares) at Mar. 31, 2024		4,676	74,282,509
Ending balance at Mar. 31, 2024	45,783,990	$ 47	$ 74,282	123,920,874	(78,215,834)	4,621
Beginning balance (in shares) at Dec. 31, 2023		4,676	74,166,262
Beginning balance at Dec. 31, 2023	51,769,087	$ 47	$ 74,166	123,125,007	(71,434,754)	4,621
Net loss	(27,374,817)
Ending balance (in shares) at Sep. 30, 2024		4,676	77,991,861
Ending balance at Sep. 30, 2024	33,849,910	$ 47	$ 77,992	132,581,442	(98,809,571)
Beginning balance (in shares) at Mar. 31, 2024		4,676	74,282,509
Beginning balance at Mar. 31, 2024	45,783,990	$ 47	$ 74,282	123,920,874	(78,215,834)	4,621
Stock based compensation	958,406			958,406
Vesting of restricted stock units (in shares)			298,144
Vesting of restricted stock units	(163,479)		$ 298	(163,777)
Net loss	(8,160,019)				(8,160,019)
Ending balance (in shares) at Jun. 30, 2024		4,676	74,580,653
Ending balance at Jun. 30, 2024	38,418,898	$ 47	$ 74,580	124,715,503	(86,375,853)	4,621
Stock based compensation	1,277,178			1,277,178
Vesting of restricted stock units (in shares)			308,735
Vesting of restricted stock units	(411,894)		$ 309	(412,203)
Exercise of warrants (in shares)			530,578
Exercise of warrants	0		$ 531	(531)
Exercise of stock options (in shares)			26,904
Exercise of stock options	4,067		$ 27	4,040
Currency translation adjustments	(4,621)					(4,621)
Acquisition of FlightWave (in shares)			2,544,991
Acquisition of FlightWave	7,000,000		$ 2,545	6,997,455
Net loss	(12,433,718)				(12,433,718)
Ending balance (in shares) at Sep. 30, 2024		4,676	77,991,861
Ending balance at Sep. 30, 2024	$ 33,849,910	$ 47	$ 77,992	132,581,442	(98,809,571)
Beginning balance (in shares) at Dec. 31, 2024	85,215,136	4,676	85,215,136
Beginning balance at Dec. 31, 2024	$ 50,119,553	$ 47	$ 85,215	174,778,994	(124,744,703)
Stock based compensation	1,598,972			1,598,972
Exercise of warrants (in shares)			49,843
Exercise of warrants	0		$ 50	(50)
Exercise of stock options (in shares)			488,969
Exercise of stock options	316,074		$ 489	315,585
Retirement of common shares (in shares)			(106,330)
Retirement of common shares	0		$ (106)	106
Net loss	(23,123,351)				(23,123,351)
Ending balance (in shares) at Mar. 31, 2025		4,676	85,647,618
Ending balance at Mar. 31, 2025	$ 28,911,248	$ 47	$ 85,648	176,693,607	(147,868,054)	0
Beginning balance (in shares) at Dec. 31, 2024	85,215,136	4,676	85,215,136
Beginning balance at Dec. 31, 2024	$ 50,119,553	$ 47	$ 85,215	174,778,994	(124,744,703)
Exercise of warrants (in shares)	559,580
Exercise of stock options (in shares)	1,997,350
Retirement of common shares (in shares)	(106,330)
Public offerings, net of issuance costs (in shares)	29,141,438
Conversion of convertible notes into common stock (in shares)	1,446,609
Net loss	$ (52,418,759)
Ending balance (in shares) at Sep. 30, 2025	118,162,270	4,676	118,162,270
Ending balance at Sep. 30, 2025	$ 253,273,869	$ 47	$ 118,162	430,319,122	(177,163,462)	0
Beginning balance (in shares) at Mar. 31, 2025		4,676	85,647,618
Beginning balance at Mar. 31, 2025	28,911,248	$ 47	$ 85,648	176,693,607	(147,868,054)	0
Stock based compensation	2,035,061			2,035,061
Exercise of warrants (in shares)			200,000
Exercise of warrants	300,000		$ 200	299,800
Exercise of stock options (in shares)			907,099
Exercise of stock options	993,463		$ 907	992,556
Public offerings, net of issuance costs (in shares)			11,172,688
Public offerings, net of issuance costs	71,768,044		$ 11,173	71,756,871
Conversion of convertible notes into common stock (in shares)			704,451
Conversion of convertible notes into common stock	4,836,266		$ 704	4,835,562
Acquisition adjustment (in shares)			(121,513)
Acquisition adjustment	0		$ (122)	122
Net loss	(13,278,960)				(13,278,960)
Ending balance (in shares) at Jun. 30, 2025		4,676	98,510,343
Ending balance at Jun. 30, 2025	95,565,122	$ 47	$ 98,510	256,613,579	(161,147,014)	0
Stock based compensation	3,621,387			3,621,387
Vesting of restricted stock units (in shares)			30,000
Vesting of restricted stock units	0		$ 30	(30)
Exercise of warrants (in shares)			309,737
Exercise of warrants	2,286,000		$ 310	2,285,690
Exercise of stock options (in shares)			601,282
Exercise of stock options	150,674		$ 601	150,073
Public offerings, net of issuance costs (in shares)			17,968,750
Public offerings, net of issuance costs	162,580,462		$ 17,969	162,562,493
Conversion of convertible notes into common stock (in shares)			742,158
Conversion of convertible notes into common stock	5,086,672		$ 742	5,085,930
Net loss	$ (16,016,448)				(16,016,448)
Ending balance (in shares) at Sep. 30, 2025	118,162,270	4,676	118,162,270
Ending balance at Sep. 30, 2025	$ 253,273,869	$ 47	$ 118,162	$ 430,319,122	$ (177,163,462)	$ 0